-
CLINICAL BURDEN AND INDIRECT COSTS ASSOCIATED WITH MORTALITY FROM HPV CANCERS: A FOCUS ON THE ITALIAN CONTEXT
Aug 11, 2026, 17:16 PM -
MAPPING THE EORTC QLQ-C30 ONTO THE EQ-5D-5L UTILITY INDEX IN PATIENTS WITH BREAST CANCER IN SPAIN
Aug 11, 2026, 17:16 PM -
WHO IS RESPONSIBLE? MAPPING THE ACCOUNTABILITY GAP FOR AI USE IN MANUFACTURER DOSSIER SUBMISSIONS TO HTA BODIES0
Aug 11, 2026, 17:16 PM -
WHEN TIME MATTERS: THE VALUE OF IN VITRO DIAGNOSTIC TESTING IN ONCOLOGY IN PORTUGAL
Aug 11, 2026, 17:16 PM -
MODIFYING THE NUMBER NEEDED TO SCREEN (NNS) TO ACCOUNT FOR THE PREVALENCE DIFFERENCE (PD) OF RISK FACTORS: A NOVEL APPROACH
Aug 11, 2026, 17:16 PM -
THE CLINICAL IMPACT OF FORMULARY RESTRICTIONS: PHARMACY CLAIM DENIALS, DEMOGRAPHIC DISPARITIES, AND HOSPITALIZATION RATES FOLLOWING PRESCRIPTION ABANDONMENT
Aug 11, 2026, 17:16 PM -
DEVELOPING AN EQ-5D-5L VALUE SET FOR QATAR
Aug 11, 2026, 17:16 PM -
AUTOMATED QUALITY CONTROL OF HEALTH ECONOMIC EXCEL MODELS USING A LARGE LANGUAGE MODEL AGENT: A MULTI-MODEL VALIDATION STUDY
Aug 11, 2026, 17:16 PM -
ESTIMATING INDIVIDUAL-LEVEL MEDICAL COST SAVINGS FROM DIGITAL CHRONIC DISEASE MANAGEMENT: A BIOMETRIC-TO-PMPM PROXY METHODOLOGY
Aug 11, 2026, 17:16 PM -
ASSOCIATION BETWEEN EORTC QLQ-C30 SUMMARY SCORE AND GLOBAL HEALTH STATUS IN CANCER PATIENTS RECEIVING CHEMOTHERAPY: A PROSPECTIVE LONGITUDINAL STUDY
Aug 11, 2026, 17:16 PM -
MIGRATION BETWEEN ACADEMIC AND COMMUNITY TREATMENT SETTINGS FROM DIAGNOSIS TO TREATMENT AMONG PATIENTS WITH BREAST CANCER: A REAL-WORLD ANALYSIS LEVERAGING NORSTELLALINQ EHR AND CLAIMS
Aug 11, 2026, 17:16 PM -
HOW AVAILABLE IS INFORMATION ON HTAR-RELATED PROCESS ADAPTATION AMONG THE 34 AUTHORITIES AND BODIES IN THE JCA SUBGROUP?
Aug 11, 2026, 17:16 PM -
DEVELOPMENT AND VALIDATION OF A VARIABLE-BASED AI PROMPT FRAMEWORK FOR AUTOMATED GENERATION OF UK NICE DOSSIER SECTIONS: A MULTI-DRUG SOURCE FIDELITY EVALUATION
Aug 11, 2026, 17:16 PM -
IMPACT OF TREATMENT STATUS ON EQ-5D-5L UTILITIES IN ALPHA-MANNOSIDOSIS: A VIGNETTE STUDY
Aug 11, 2026, 17:16 PM -
UNLOCKING CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) DISEASE STAGE IN REAL-WORLD DATA: CLINICAL NOTES AS THE PRIMARY SOURCE OF RAI AND BINET STAGING INFORMATION USING NORSTELLALINQ
Aug 11, 2026, 17:16 PM -
EPIDEMIOLOGY, DIAGNOSIS AND TREATMENT OF CHRONIC SPONTANEOUS URTICARIA IN TURKIYE: RESULTS OF A DELPHI PANEL
Aug 11, 2026, 17:16 PM -
QUANTIFYING PREFERENCES FOR TYPE 2 DIABETES TREATMENTS AMONGST INDIVIDUALS IN ITALY: A DISCRETE CHOICE EXPERIMENT
Aug 11, 2026, 17:16 PM -
ONE SIZE FITS ALL? RARE DISEASES AND ADVANCED THERAPIES UNDER THE EU JOINT CLINICAL ASSESSMENT FRAMEWORK
Aug 11, 2026, 17:16 PM -
CLINICAL AND ECONOMIC IMPACT OF CARDIOVASCULAR AND CEREBROVASCULAR COMORBIDITIES IN MENOPAUSAL WOMEN WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS IN SPAIN
Aug 11, 2026, 17:16 PM -
GENE THERAPY PREFERENCES: AN INTERVIEW STUDY WITH PEOPLE WITH CYSTIC FIBROSIS AND THEIR CAREGIVERS
Aug 11, 2026, 17:16 PM
